Manufacturers Life Insurance Company, The Replimune Group, Inc. Transaction History

Manufacturers Life Insurance Company, The

$108 Billion
Q3 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Replimune Group, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 184,208 shares of REPL stock, worth $2.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

184,208

Previous 147,519 24.87%

Holding current value

$2.65 Million

Previous $1.33 Million 52.07%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$8.09 - $11.23 $296,814 - $412,017	36,689 Added 24.87%	184,208 $2.02 Million
Q2 2024 Aug 14, 2024	SELL	$5.01 - $9.46 $3,271 - $6,177	-653 Reduced 0.44%	147,519 $1.33 Million
Q1 2024 May 14, 2024	SELL	$6.87 - $9.31 $45,177 - $61,222	-6,576 Reduced 4.25%	148,172 $1.21 Million
Q4 2023 Feb 13, 2024	BUY	$6.75 - $16.18 $162,580 - $389,711	24,086 Added 18.43%	154,748 $1.3 Million
Q3 2023 Nov 15, 2023	BUY	$15.96 - $22.18 $254,147 - $353,194	15,924 Added 13.88%	130,662 $2.24 Million
Q2 2023 Aug 11, 2023	BUY	$15.65 - $24.1 $199,709 - $307,540	12,761 Added 12.51%	114,738 $2.66 Million
Q1 2023 May 15, 2023	BUY	$17.48 - $29.09 $218,674 - $363,915	12,510 Added 12.27%	114,487 $2.02 Million
Q4 2022 Aug 11, 2023	BUY	$17.09 - $27.91 $414,466 - $676,873	24,252 Added 31.2%	101,977 $2.77 Million
Q4 2022 Feb 13, 2023	BUY	$17.09 - $27.91 $414,466 - $676,873	24,252 Added 31.2%	101,977 $2.77 Million
Q3 2022 Aug 11, 2023	SELL	$15.6 - $21.15 $3,572 - $4,843	-229 Reduced 0.29%	77,725 $1.34 Million
Q3 2022 Nov 03, 2022	SELL	$15.6 - $21.15 $3,572 - $4,843	-229 Reduced 0.29%	77,725 $1.3 Million
Q2 2022 Aug 11, 2023	SELL	$13.32 - $19.98 $7,845 - $11,768	-589 Reduced 0.75%	77,954 $1.36 Million
Q2 2022 Aug 15, 2022	SELL	$13.32 - $19.98 $7,845 - $11,768	-589 Reduced 0.75%	77,954 $1.36 Million
Q1 2022 Aug 11, 2023	SELL	$15.24 - $29.75 $547,786 - $1.07 Million	-35,944 Reduced 31.4%	78,543 $1.33 Million
Q1 2022 May 20, 2022	BUY	$15.24 - $29.75 $951,326 - $1.86 Million	62,423 Added 387.24%	78,543 $1.34 Million
Q4 2021 Feb 16, 2022	BUY	$25.43 - $34.25 $4,450 - $5,993	175 Added 1.1%	16,120 $445,000
Q3 2021 Nov 12, 2021	BUY	$28.98 - $39.54 $13,620 - $18,583	470 Added 3.04%	15,945 $473,000
Q2 2021 Aug 12, 2021	BUY	$28.5 - $39.37 $39,016 - $53,897	1,369 Added 9.71%	15,475 $595,000
Q1 2021 May 03, 2021	SELL	$30.22 - $45.57 $8,098 - $12,212	-268 Reduced 1.86%	14,106 $430,000
Q4 2020 Feb 12, 2021	BUY	$23.5 - $52.65 $55,013 - $123,253	2,341 Added 19.45%	14,374 $548,000
Q3 2020 Nov 09, 2020	BUY	$18.85 - $27.0 $24,467 - $35,046	1,298 Added 12.09%	12,033 $277,000
Q2 2020 Aug 10, 2020	BUY	$9.76 - $25.95 $104,773 - $278,573	10,735 New	10,735 $269,000

Others Institutions Holding REPL

# of Institutions

149

Shares Held

68M

Call Options Held

52.3K

Put Options Held

80.3K

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $709M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account

Manufacturers Life Insurance Company, The Replimune Group, Inc. Transaction History